Confocal Laser Endomicroscopy in Patients With Eosinophilic Esophagitis
- Conditions
- Eosinophilic Esophagitis
- Interventions
- Device: Confocal laser endomicroscopy
- Registration Number
- NCT01234376
- Lead Sponsor
- University of Erlangen-Nürnberg Medical School
- Brief Summary
Confocal laser endomicroscopy enables in vivo microscopic imaging within the mucosa layer of the gut at a subcellular resolution. Various studies have addressed the potential of endomicroscopy for the in vivo diagnosis of esophageal squamous cell carcinoma, Barrett´s esophagus and esophageal adenocarcinoma. Currently, there is only one case report from our group who noted the utility of endomicroscopy for the in vivo diagnosis of eosinophilic esophagitis.
The purpose of this study is to determine whether endomicroscopy is effective for the in vivo diagnosis of eosinophilic esophagitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 45
- Written informed consent
- Age 18-85 years
- Ability of subjects to understand character and individual consequences of clinical trial
- Subjects undergoing EGD
- Inability to provide written informed consent
- Severe Coagulopathy (Prothrombin time < 50% of control, Partial thromboplastin time > 50 s)
- Impaired renal function (Creatinine > 1.2 mg/dl)
- Pregnancy or breast feeding
- Active gastrointestinal bleeding
- Known allergy to fluorescein, acriflavin or cresyl violet
- Residing in institutions (e.g. prison)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with eosinophilic esophagitis Confocal laser endomicroscopy - Control patients Confocal laser endomicroscopy -
- Primary Outcome Measures
Name Time Method Effectiveness of endomicroscopy for the in vivo diagnosis of eosinophilic esophagitis November 2010 - November 2012
- Secondary Outcome Measures
Name Time Method Differentiation of mucosal alterations in patients with eosinophilic esophagitis compared to patients with gastroesophageal reflux disease. November 2010 - November 2012
Trial Locations
- Locations (1)
University of Erlangen-Nuremberg
🇩🇪Erlangen, Bayern, Germany